Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease?
Open Access
- 2 April 2003
- journal article
- Published by Wiley in FEBS Letters
- Vol. 541 (1-3), 145-148
- https://doi.org/10.1016/s0014-5793(03)00277-1
Abstract
Presenilin 1 (PS1) is a key factor for β‐amyloid (Ab) formation in Alzheimer disease (AD). Homocysteine accumulation, frequently observed in AD patients, may be a sign of a metabolic alteration in th...Keywords
This publication has 28 references indexed in Scilit:
- Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- S‐Adenosylmethionine: a control switch that regulates liver functionThe FASEB Journal, 2002
- The Dynamics of Myogenin Site-specific Demethylation Is Strongly Correlated with Its Expression and with Muscle DifferentiationJournal of Biological Chemistry, 2001
- Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasmaFree Radical Biology & Medicine, 2001
- MinireviewBiological Chemistry, 1998
- Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesodermNature, 1997
- Influence of vitamin B12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's typeJournal of Neural Transmission, 1996
- Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disordersEuropean Neuropsychopharmacology, 1995
- S-adenosylmethionine levels in psychiatric and neurological disorders: a reviewActa Neurologica Scandinavica, 1994